Olin Announces Second Quarter 2026 Results
Neutral to modestly bullish over 12–18 months on completion of the Huntsman merger and stabilization of Chemical segments.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Neutral to modestly bullish over 12–18 months on completion of the Huntsman merger and stabilization of Chemical segments.
What happened and why it matters
Olin reported a Q2 2026 net loss of $13.3M but delivered $191.3M in adjusted EBITDA on $1.742B in sales, with Sequential EBITDA gains offset by a Freeport VCM plant disruption. The company reiterated guidance for a Q3 EBITDA range of $160–$200M and announced a definitive all-stock merger with Huntsman expected to close in early 2027, a potential source of material synergies. Leverage sits around 5x with $1.2B of liquidity, suggesting near-term funding and integration risks but potential longer-term upside if the merger succeeds.
The quarter shows a modest negative near-term delta (net loss) but a meaningful EBITDA beat on a non-GAAP basis and a major strategic merger that could unlock value if approvals and integration benefit materialize. In similar cycles, M&A-driven re-ratings occur upon closing with clearer synergy realization; until then, fundamentals are mixed and stock sensitivity centers on merger progress and leverage management.
Q2 2026 net loss of $13.3M; diluted EPS $(0.12).
Adjusted EBITDA $191.3M; excludes $122.1M D&A, $10.6M acquisition costs, $10.5M restructuring.
Freeport vinyl chloride monomer outage cut Q2 EBITDA by $40M; $20M expected in Q3.
Olin/Huntsman propose a merger of equals; closing targeted in first half of 2027.
Debt/EBITDA 5.0x; liquidity $1.2B; net debt $2.85B; Shintech settlements ~$93M paid
Earnings with a strategic M&A angle; OLN is balancing near-term margin headwinds with a major merger that could unlock longer-term value.
More AI-analyzed coverage connected to this story